WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

COMPUTER-AIDED DRUGS DESIGN OF BIOINFORMATICS AND ADME DATABASE

Asgar Shameem*, Manoj Yadav, Shashikant Maury and Piyush Yadav

ABSTRACT

Bioinformatics is an important area because it has allowed scientists to map the entire human genome computationally. A large amount of biological data can be stored in bioinformatics databases and retrieved using biological tools. Its application in medicine is the creation of drugs that only target diseased genes. ADME database also contains the updated & comprehensive data on interactions of substances with drug metabolising enzymes & drug transporters. It is intended for use in drug research & development, including drug-drug interactions & ADME studies.

Keywords: CADD, Bioinformatics, SBDD, LBDD, Software, ADME, Database.


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More